IGF1R and adrenal cortex carcinoma: Overexpression of the IGF2 and IGF1R genes was described in ACT also in the pediatric setting (41), but trials testing the utility of insulin like growth factor receptor 1 inhibitors (e.g., linsitinib) have failed to provide advantage for adulthood ACC treatment (42).